LED Light Therapy for Alopecia
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to determine if the Revian Red All LED cap shows potential to be an effective treatment for Central centrifugal cicatricial alopecia (CCCA) by recruiting hair follicles back to anagen growth or by improving inflammation. The primary outcome is to determine if hair loss regression is halted. Secondary outcomes include hair regrowth and alleviation of signs and symptoms of the disease.Participants will be asked to use the Revian Red All LED cap once daily for a 10-minute treatment regimen which is the current androgenetic alopecia recommendation.
Who Is on the Research Team?
Amy McMichael, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for women aged 18-65 with a biopsy-proven diagnosis of Central centrifugal cicatricial alopecia (CCCA) stages II-IV. Participants must have been on stable treatment, such as doxycycline or minoxidil, without changes for at least 3 months. Men and those with other forms of hair loss are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the Revian Red All LED cap once daily for a 10-minute treatment regimen over 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Revian Red All LED Cap
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor